Biomarkers in Drug Discovery & Development

Biomarkers are fast becoming an essential part of clinical development, because they offer a faster alternative to the conventional drug development approach and also safe drugs in greater number .The global market of biomarkers was valued at USD 23.9 billion in 2015 and the global market of biomarkers is expected to reach $45.55 billion by 2020 from $23.9, and at a CAGR of 13.58% between 2015 and 2020. Increasing health care expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection &and storage are the major factors restraining the growth of this market

  • Biomarker Discovery & Identification Strategies
  • Biomarkers from Qualification to Validation
  • Biomarkers of Translational Medicine: Safety, PK/PD, & Efficacy
  • Biomarkers in Personalized Medicine
  • Biomarkers in Diagnostics
  • Biomarkers in Clinical Development & Clinical Trials
  • Clinical Trials & Developments
  • Companion Diagnostics Development & Commercialization 
  • Cell-free DNA & RNA Technologies & Their Platforms
  • Clinical Applications of Cell-Free DNA & RNA in Disease Diagnosis & Management
  • New Developments in Cell-Free Biomarkers

Related Conference of Biomarkers in Drug Discovery & Development

September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Biomarkers in Drug Discovery & Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in